(Q41523547)

2 October 2017

1 reference

title

Systemic lupus erythematosus and multiple myeloma: a rare association (English)

1 reference

2 October 2017

A Afeltra

1

1 reference

2 October 2017

A Amoroso

2

1 reference

2 October 2017

P Garzia

3

1 reference

2 October 2017

M A Addessi

4

1 reference

2 October 2017

A Pulsoni

5

1 reference

2 October 2017

L Bonomo

6

1 reference

2 October 2017

1 June 1997

1 reference

Seminars in Arthritis and Rheumatism

2 October 2017

1 reference

2 October 2017

26

1 reference

2 October 2017

6

1 reference

2 October 2017

845-849

1 reference

Cancer in connective tissue disease

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Increased risk of cancer in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Malignancy in a series of 70 patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Systemic lupus erythematosus--survival patterns. Experience with 609 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Systemic lupus erythematosus and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Malignancy in systemic lupus erythematosus: a report of five cases in a series of 96 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Systemic Lupus Erythematosus and Chronic Lymphocytic Leukemia: Rare Coexistence in Three Patients, with Comments on Pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Multiple myeloma complicating the course of seronegative systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Radiologic findings in late-onset systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Discoid lupus erythematosus and monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Anaplastic myeloma in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Systemic lupus erythematosus occurring in a patient with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Systemic lupus erythematosus in association with smoldering multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Systemic lupus erythematosus with paraproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Amyloidosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Family history of autoimmune disorders and cancer in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

The association of malignancy with SLE: an analysis of 150 patients under long-term review

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. The Nordic Myeloma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2897%2980029-7

7 January 2021

10.1016/S0049-0172(97)80029-7

Identifiers

DOI

1 reference

release_3o6cur65bzc4diecg5fzcd4lai

2 October 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3o6cur65bzc4diecg5fzcd4lai

24 November 2022

mapped directly with Wikidata item

1 reference